SciSparc (SPRC) Other Non-Current Assets (2017 - 2025)
SciSparc (SPRC) posted Other Non-Current Assets of $7.6 million for Q4 2025, up 2238.04% sequentially from $326000.0 in Q2 2025, and down 25.06% YoY from $10.2 million in Q4 2024.
SciSparc (SPRC) Other Non-Current Assets (2017 - 2025) Analysis & Trends
SciSparc has reported Other Non-Current Assets for 9 years, with the latest figure at $7.6 million in Q4 2025.
- Quarterly Other Non-Current Assets fell 25.06% year-over-year to $7.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.6 million (down 25.06% YoY) and the FY2025 annual result came in at $7.6 million, down 25.06% from the prior year.
- Other Non-Current Assets rose to $7.6 million in Q4 2025 per SPRC's latest filing, from $326000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $10.2 million in Q4 2024 and troughed at -$1.5 million in Q4 2022.
- A 5-year average of $2.8 million and a median of $531000.0 in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2021 and 2022: Other Non-Current Assets soared 99060.0% in 2021, then plunged 115.13% in 2022.
- Over 5 years, Other Non-Current Assets stood at $9.9 million in 2021, then sank by 115.13% to -$1.5 million in 2022, then surged by 143.93% to $659000.0 in 2023, then soared by 1443.4% to $10.2 million in 2024, then declined by 25.06% to $7.6 million in 2025.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $7.6 million, $326000.0, and $10.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | SciSparc | 831,418.60 | 831,418.60 | - | 7.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.62 Mn |
| Jun 30, 2025 | 326,000.00 |
| Dec 31, 2024 | 10.17 Mn |
| Jun 30, 2024 | 403,000.00 |
| Dec 31, 2023 | 659,000.00 |
| Jun 30, 2023 | 849,000.00 |
| Dec 31, 2022 | -1.50 Mn |
| Jun 30, 2022 | 40,000.00 |
| Dec 31, 2021 | 9.92 Mn |
| Jun 30, 2021 | 11,000.00 |
| Dec 31, 2020 | 10,000.00 |
| Jun 30, 2020 | 34,000.00 |
| Dec 31, 2019 | 24,000.00 |
| Jun 30, 2019 | 24,000.00 |
| Dec 31, 2018 | 23,000.00 |
| Sep 30, 2018 | 23,000.00 |
| Jun 30, 2018 | 23,000.00 |
| Dec 31, 2017 | 24,000.00 |
| Jun 30, 2017 | 13,000.00 |